Treatment of defects of cellular immunity with leukocyte...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 35/14 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2580616

The invention relates to a composition consisting of proteins, peptides and/or peptide constituents, a pharmaceutical product containing said composition, a method for producing said composition, and the use thereof for the prophylaxis or therapy of people and/or patients with pathogenic modifications and/or defects of cellular immunity, especially cancer, sepsis or allergic reactions, in conjunction with cytostatic therapy, chemotherapy and/or radiotherapy.

L'invention concerne une composition constituée de protéines, de peptides et/ou de constituants peptidiques, un produit pharmaceutique comprenant cette composition, un procédé pour produire cette composition, ainsi que l'utilisation de cette composition pour protéger ou traiter des personnes et/ou des patients présentant des modifications et/ou des défauts pathogènes de l'immunité cellulaire, notamment un cancer, une septicémie ou des réactions allergiques, en relation avec une thérapie par cytostatiques, une chimiothérapie et/ou une radiothérapie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of defects of cellular immunity with leukocyte... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of defects of cellular immunity with leukocyte..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of defects of cellular immunity with leukocyte... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2009275

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.